Skip to content

Analgesic Effects of Repeated Transcranial Electrical Stimulation Targeting the Primary Motor Cortex in Experimental Pain among Healthy Participants

Analgesic Effects and Mechanisms of Repeated Transcranial Electrical Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116368
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-10
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

tDCS treatment group:A 3-day M1-tDCS intervention, with 20 minutes per day. Stimulation pattern: anodal tDCS with target over the M1 and a current intensity of 1mA.
tRNS treatment group:A 3-day intervention targeting the M1, with 20 minutes per day. Stimulation pattern: tRNS+DC-offset, with target over the M1 and a current intensity of 1mA.
Sham group:A 3-day sham intervention, with 20 minutes per day. Stimulation pattern: sham stimulation, with target over the M1 and a current intensity of 1mA.

Sponsors

School of Psychology, Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-65 years, regardless of gender; 2.No history of epilepsy, neurological disorders, acute or chronic pain conditions, claustrophobia, or contraindications to transcranial magnetic stimulation (TMS); 3.Participants must provide written informed consent and agree to participate in this study; 4.Have not undergone any physical therapy treatments, such as repeated transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), or transcranial alternating current stimulation (tACS) within the past 1 months.

Exclusion criteria

Exclusion criteria: 1.Psychiatric disorders (bipolar disorder, depression, etc.), neurological disorders (epilepsy, Alzheimer's disease, multiple sclerosis, Parkinson's disease, motor neuron disease), history of brain surgery or tumors, heart disease, rheumatic/inflammatory diseases (e.g., rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus, Sjögren's syndrome); 2.Metal on or inside the body; 3.Pregnancy; 4.History of drug or other substance dependence; 5.Use of analgesic-related medications within the last 3 days;

Design outcomes

Primary

MeasureTime frame
Pain intensity;Pain unpleasantness;Pain sensitivity trait;Conditioned pain modulation;Temporal summation of pain;TMS-induced brain response;EEG resting-state brain activity;fMRI resting-state brain activity;

Countries

China

Contacts

Public ContactWeiwei Peng

School of Psychology, Shenzhen University

ww.peng0923@gmail.com+86 183 7591 7850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026